Subscribe
shutterstock_399778786_paul_brady_photography
Paul Brady Photography / Shutterstock.com
9 October 2019AmericasSarah Morgan

California outlaws pay-for-delay deals

California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
California mulls state generics brand
13 January 2020   California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.
Americas
California pay-for-delay ban upheld during appeal, rules Ninth Circuit
25 February 2020   The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.
Americas
Par avoids pay-for-delay suit after court accepts payment was ‘fair’
10 March 2020   A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
California mulls state generics brand
13 January 2020   California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.
Americas
California pay-for-delay ban upheld during appeal, rules Ninth Circuit
25 February 2020   The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.
Americas
Par avoids pay-for-delay suit after court accepts payment was ‘fair’
10 March 2020   A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More on this story

Americas
California mulls state generics brand
13 January 2020   California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.
Americas
California pay-for-delay ban upheld during appeal, rules Ninth Circuit
25 February 2020   The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.
Americas
Par avoids pay-for-delay suit after court accepts payment was ‘fair’
10 March 2020   A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?